APO Research
Talk to an analyst

APO RESEARCH · REPORT

Praziquantel

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Praziquantel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchPraziquantel Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Praziquantel Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Praziquantel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Praziquantel Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Praziquantel Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Praziquantel market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Praziquantel include Zoetis, Merck, Bayer, Soparfin, Shin Poong Pharm, Richter Pharma, Norbrook Laboratories, Merial and Mavlab Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Praziquantel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Praziquantel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Praziquantel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Praziquantel market size, projected growth trends, production technologies, key applications, and end-use industries.

Praziquantel Segment by Company

Zoetis

Merck

Bayer

Soparfin

Shin Poong Pharm

Richter Pharma

Norbrook Laboratories

Merial

Mavlab Animal Health

Lavet Pharmaceuticals

Kyron Pharma

Krka

Ecuphar

Covetrus

CiplaVet

Chanelle Pharma

Ceva Santé Animale

C and H Generics

Auvex

AniMedica

Praziquantel Segment by Type

Patent

Generic

Praziquantel Segment by Application

Liver Fluke Infection

Cysticercosis

Cestode Infections

Trematode Infections

Schistosoma Infection

Others

Praziquantel Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Praziquantel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Praziquantel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Praziquantel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Praziquantel market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Praziquantel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Praziquantel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Praziquantel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Praziquantel Industry Trends Table 2. Praziquantel Industry Drivers Table 3. Praziquantel Industry Opportunities and Challenges Table 4. Praziquantel Industry Restraints Table 5. Global Praziquantel Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Praziquantel Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Praziquantel Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Praziquantel Sales Market Share by Manufacturers Table 9. Global Praziquantel Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Praziquantel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Praziquantel Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Praziquantel Manufacturers, Product Type & Application Table 13. Global Praziquantel Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Praziquantel by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Patent Table 17. Major Manufacturers of Generic Table 18. Global Praziquantel Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Praziquantel Sales by Type (2021-2026) & (K Units) Table 20. Global Praziquantel Sales by Type (2027-2032) & (K Units) Table 21. Global Praziquantel Sales Market Share by Type (2021-2026) Table 22. Global Praziquantel Sales Market Share by Type (2027-2032) Table 23. Global Praziquantel Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Praziquantel Revenue by Type (2021-2026) & (K Units) Table 25. Global Praziquantel Revenue by Type (2027-2032) & (K Units) Table 26. Global Praziquantel Revenue Market Share by Type (2021-2026) Table 27. Global Praziquantel Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Liver Fluke Infection Table 29. Major Manufacturers of Cysticercosis Table 30. Major Manufacturers of Cestode Infections Table 31. Major Manufacturers of Trematode Infections Table 32. Major Manufacturers of Schistosoma Infection Table 33. Major Manufacturers of Others Table 34. Global Praziquantel Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Praziquantel Sales by Application (2021-2026) & (K Units) Table 36. Global Praziquantel Sales by Application (2027-2032) & (K Units) Table 37. Global Praziquantel Sales Market Share by Application (2021-2026) Table 38. Global Praziquantel Sales Market Share by Application (2027-2032) Table 39. Global Praziquantel Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Praziquantel Revenue by Application (2021-2026) & (K Units) Table 41. Global Praziquantel Revenue by Application (2027-2032) & (K Units) Table 42. Global Praziquantel Revenue Market Share by Application (2021-2026) Table 43. Global Praziquantel Revenue Market Share by Application (2027-2032) Table 44. Global Praziquantel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Praziquantel Sales by Region (2021-2026) & (K Units) Table 46. Global Praziquantel Sales Market Share by Region (2021-2026) Table 47. Global Praziquantel Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Praziquantel Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Praziquantel Sales by Country (2021-2026) & (K Units) Table 51. North America Praziquantel Sales by Country (2027-2032) & (K Units) Table 52. Europe Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Praziquantel Sales by Country (2021-2026) & (K Units) Table 54. Europe Praziquantel Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Praziquantel Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Praziquantel Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Praziquantel Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Praziquantel Sales by Country (2027-2032) & (K Units) Table 61. Global Praziquantel Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Praziquantel Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Praziquantel Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Praziquantel Revenue Market Share by Region (2021-2026) Table 65. Global Praziquantel Revenue Market Share by Region (2027-2032) Table 66. Zoetis Company Information Table 67. Zoetis Business Overview Table 68. Zoetis Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zoetis Praziquantel Product Portfolio Table 70. Zoetis Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Merck Praziquantel Product Portfolio Table 75. Merck Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Bayer Praziquantel Product Portfolio Table 80. Bayer Recent Development Table 81. Soparfin Company Information Table 82. Soparfin Business Overview Table 83. Soparfin Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Soparfin Praziquantel Product Portfolio Table 85. Soparfin Recent Development Table 86. Shin Poong Pharm Company Information Table 87. Shin Poong Pharm Business Overview Table 88. Shin Poong Pharm Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Shin Poong Pharm Praziquantel Product Portfolio Table 90. Shin Poong Pharm Recent Development Table 91. Richter Pharma Company Information Table 92. Richter Pharma Business Overview Table 93. Richter Pharma Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Richter Pharma Praziquantel Product Portfolio Table 95. Richter Pharma Recent Development Table 96. Norbrook Laboratories Company Information Table 97. Norbrook Laboratories Business Overview Table 98. Norbrook Laboratories Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Norbrook Laboratories Praziquantel Product Portfolio Table 100. Norbrook Laboratories Recent Development Table 101. Merial Company Information Table 102. Merial Business Overview Table 103. Merial Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Merial Praziquantel Product Portfolio Table 105. Merial Recent Development Table 106. Mavlab Animal Health Company Information Table 107. Mavlab Animal Health Business Overview Table 108. Mavlab Animal Health Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Mavlab Animal Health Praziquantel Product Portfolio Table 110. Mavlab Animal Health Recent Development Table 111. Lavet Pharmaceuticals Company Information Table 112. Lavet Pharmaceuticals Business Overview Table 113. Lavet Pharmaceuticals Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Lavet Pharmaceuticals Praziquantel Product Portfolio Table 115. Lavet Pharmaceuticals Recent Development Table 116. Kyron Pharma Company Information Table 117. Kyron Pharma Business Overview Table 118. Kyron Pharma Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Kyron Pharma Praziquantel Product Portfolio Table 120. Kyron Pharma Recent Development Table 121. Krka Company Information Table 122. Krka Business Overview Table 123. Krka Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Krka Praziquantel Product Portfolio Table 125. Krka Recent Development Table 126. Ecuphar Company Information Table 127. Ecuphar Business Overview Table 128. Ecuphar Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Ecuphar Praziquantel Product Portfolio Table 130. Ecuphar Recent Development Table 131. Covetrus Company Information Table 132. Covetrus Business Overview Table 133. Covetrus Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Covetrus Praziquantel Product Portfolio Table 135. Covetrus Recent Development Table 136. CiplaVet Company Information Table 137. CiplaVet Business Overview Table 138. CiplaVet Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. CiplaVet Praziquantel Product Portfolio Table 140. CiplaVet Recent Development Table 141. Chanelle Pharma Company Information Table 142. Chanelle Pharma Business Overview Table 143. Chanelle Pharma Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Chanelle Pharma Praziquantel Product Portfolio Table 145. Chanelle Pharma Recent Development Table 146. Ceva Santé Animale Company Information Table 147. Ceva Santé Animale Business Overview Table 148. Ceva Santé Animale Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Ceva Santé Animale Praziquantel Product Portfolio Table 150. Ceva Santé Animale Recent Development Table 151. C and H Generics Company Information Table 152. C and H Generics Business Overview Table 153. C and H Generics Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. C and H Generics Praziquantel Product Portfolio Table 155. C and H Generics Recent Development Table 156. Auvex Company Information Table 157. Auvex Business Overview Table 158. Auvex Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Auvex Praziquantel Product Portfolio Table 160. Auvex Recent Development Table 161. AniMedica Company Information Table 162. AniMedica Business Overview Table 163. AniMedica Praziquantel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. AniMedica Praziquantel Product Portfolio Table 165. AniMedica Recent Development Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Praziquantel Distributors List Table 169. Praziquantel Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Praziquantel Product Image Figure 2. Global Praziquantel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Praziquantel Market Size (2021-2032) & (US$ Million) Figure 4. Global Praziquantel Sales (2021-2032) & (K Units) Figure 5. Global Praziquantel Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Praziquantel Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Patent Image Figure 9. Generic Image Figure 10. Global Praziquantel Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Praziquantel Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Praziquantel Sales Market Share by Type (2021-2032) Figure 13. Global Praziquantel Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Praziquantel Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Praziquantel Revenue Market Share by Type (2021-2032) Figure 16. Liver Fluke Infection Image Figure 17. Cysticercosis Image Figure 18. Cestode Infections Image Figure 19. Trematode Infections Image Figure 20. Schistosoma Infection Image Figure 21. Others Image Figure 22. Global Praziquantel Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Praziquantel Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Praziquantel Sales Market Share by Application (2021-2032) Figure 25. Global Praziquantel Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Praziquantel Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Praziquantel Revenue Market Share by Application (2021-2032) Figure 28. North America Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Praziquantel Sales Market Share by Country (2021-2032) Figure 30. U.S. Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Praziquantel Sales Market Share by Country (2021-2032) Figure 35. Germany Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Praziquantel Sales Market Share by Country (2021-2032) Figure 42. China Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Praziquantel Sales Market Share by Country (2021-2032) Figure 50. Brazil Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Praziquantel Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Praziquantel Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Praziquantel Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Praziquantel Revenue (2021-2032) & (US$ Million) Figure 61. North America Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Praziquantel Revenue (2021-2032) & (US$ Million) Figure 63. Europe Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Praziquantel Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Praziquantel Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Praziquantel Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Praziquantel Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • Liver Fluke Infection
  • Cysticercosis
  • Cestode Infections
  • Trematode Infections
  • Schistosoma Infection
  • Others
Companies covered
  • Zoetis
  • Merck
  • Bayer
  • Soparfin
  • Shin Poong Pharm
  • Richter Pharma
  • Norbrook Laboratories
  • Merial
  • Mavlab Animal Health
  • Lavet Pharmaceuticals
  • Kyron Pharma
  • Krka
  • Ecuphar
  • Covetrus
  • CiplaVet
  • Chanelle Pharma
  • Ceva Santé Animale
  • C and H Generics
  • Auvex
  • AniMedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Praziquantel Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Praziquantel Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Praziquantel Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Praziquantel Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Praziquantel Market Dynamics
  1. 2.1 Praziquantel Industry Trends
  2. 2.2 Praziquantel Industry Drivers
  3. 2.3 Praziquantel Industry Opportunities and Challenges
  4. 2.4 Praziquantel Industry Restraints
3 Praziquantel Market by Manufacturers
  1. 3.1 Global Praziquantel Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Praziquantel Sales by Manufacturers (2021-2026)
  3. 3.3 Global Praziquantel Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Praziquantel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Praziquantel Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Praziquantel Manufacturers, Product Type & Application
  7. 3.7 Global Praziquantel Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Praziquantel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Praziquantel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Praziquantel Tier 1, Tier 2, and Tier 3
4 Praziquantel Market by Type
  1. 4.1 Praziquantel Type Introduction
  2. 4.1.1 Patent
  3. 4.1.2 Generic
  4. 4.2 Global Praziquantel Sales by Type
  5. 4.2.1 Global Praziquantel Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Praziquantel Sales by Type (2021-2032)
  7. 4.2.3 Global Praziquantel Sales Market Share by Type (2021-2032)
  8. 4.3 Global Praziquantel Revenue by Type
  9. 4.3.1 Global Praziquantel Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Praziquantel Revenue by Type (2021-2032)
  11. 4.3.3 Global Praziquantel Revenue Market Share by Type (2021-2032)
5 Praziquantel Market by Application
  1. 5.1 Praziquantel Application Introduction
  2. 5.1.1 Liver Fluke Infection
  3. 5.1.2 Cysticercosis
  4. 5.1.3 Cestode Infections
  5. 5.1.4 Trematode Infections
  6. 5.1.5 Schistosoma Infection
  7. 5.1.6 Others
  8. 5.2 Global Praziquantel Sales by Application
  9. 5.2.1 Global Praziquantel Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Praziquantel Sales by Application (2021-2032)
  11. 5.2.3 Global Praziquantel Sales Market Share by Application (2021-2032)
  12. 5.3 Global Praziquantel Revenue by Application
  13. 5.3.1 Global Praziquantel Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Praziquantel Revenue by Application (2021-2032)
  15. 5.3.3 Global Praziquantel Revenue Market Share by Application (2021-2032)
6 Global Praziquantel Sales by Region
  1. 6.1 Global Praziquantel Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Praziquantel Sales by Region (2021-2032)
  3. 6.2.1 Global Praziquantel Sales by Region (2021-2026)
  4. 6.2.2 Global Praziquantel Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Praziquantel Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Praziquantel Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Praziquantel Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Praziquantel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Praziquantel Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Praziquantel Revenue by Region
  1. 7.1 Global Praziquantel Revenue by Region
  2. 7.1.1 Global Praziquantel Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Praziquantel Revenue by Region (2021-2026)
  4. 7.1.3 Global Praziquantel Revenue by Region (2027-2032)
  5. 7.1.4 Global Praziquantel Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Praziquantel Revenue (2021-2032)
  8. 7.2.2 North America Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Praziquantel Revenue (2021-2032)
  11. 7.3.2 Europe Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Praziquantel Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Praziquantel Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Praziquantel Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Praziquantel Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Praziquantel Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Praziquantel Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Soparfin
  20. 8.4.1 Soparfin Company Information
  21. 8.4.2 Soparfin Business Overview
  22. 8.4.3 Soparfin Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Soparfin Praziquantel Product Portfolio
  24. 8.4.5 Soparfin Recent Developments
  25. 8.5 Shin Poong Pharm
  26. 8.5.1 Shin Poong Pharm Company Information
  27. 8.5.2 Shin Poong Pharm Business Overview
  28. 8.5.3 Shin Poong Pharm Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shin Poong Pharm Praziquantel Product Portfolio
  30. 8.5.5 Shin Poong Pharm Recent Developments
  31. 8.6 Richter Pharma
  32. 8.6.1 Richter Pharma Company Information
  33. 8.6.2 Richter Pharma Business Overview
  34. 8.6.3 Richter Pharma Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Richter Pharma Praziquantel Product Portfolio
  36. 8.6.5 Richter Pharma Recent Developments
  37. 8.7 Norbrook Laboratories
  38. 8.7.1 Norbrook Laboratories Company Information
  39. 8.7.2 Norbrook Laboratories Business Overview
  40. 8.7.3 Norbrook Laboratories Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Norbrook Laboratories Praziquantel Product Portfolio
  42. 8.7.5 Norbrook Laboratories Recent Developments
  43. 8.8 Merial
  44. 8.8.1 Merial Company Information
  45. 8.8.2 Merial Business Overview
  46. 8.8.3 Merial Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merial Praziquantel Product Portfolio
  48. 8.8.5 Merial Recent Developments
  49. 8.9 Mavlab Animal Health
  50. 8.9.1 Mavlab Animal Health Company Information
  51. 8.9.2 Mavlab Animal Health Business Overview
  52. 8.9.3 Mavlab Animal Health Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mavlab Animal Health Praziquantel Product Portfolio
  54. 8.9.5 Mavlab Animal Health Recent Developments
  55. 8.10 Lavet Pharmaceuticals
  56. 8.10.1 Lavet Pharmaceuticals Company Information
  57. 8.10.2 Lavet Pharmaceuticals Business Overview
  58. 8.10.3 Lavet Pharmaceuticals Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lavet Pharmaceuticals Praziquantel Product Portfolio
  60. 8.10.5 Lavet Pharmaceuticals Recent Developments
  61. 8.11 Kyron Pharma
  62. 8.11.1 Kyron Pharma Company Information
  63. 8.11.2 Kyron Pharma Business Overview
  64. 8.11.3 Kyron Pharma Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kyron Pharma Praziquantel Product Portfolio
  66. 8.11.5 Kyron Pharma Recent Developments
  67. 8.12 Krka
  68. 8.12.1 Krka Company Information
  69. 8.12.2 Krka Business Overview
  70. 8.12.3 Krka Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Krka Praziquantel Product Portfolio
  72. 8.12.5 Krka Recent Developments
  73. 8.13 Ecuphar
  74. 8.13.1 Ecuphar Company Information
  75. 8.13.2 Ecuphar Business Overview
  76. 8.13.3 Ecuphar Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ecuphar Praziquantel Product Portfolio
  78. 8.13.5 Ecuphar Recent Developments
  79. 8.14 Covetrus
  80. 8.14.1 Covetrus Company Information
  81. 8.14.2 Covetrus Business Overview
  82. 8.14.3 Covetrus Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Covetrus Praziquantel Product Portfolio
  84. 8.14.5 Covetrus Recent Developments
  85. 8.15 CiplaVet
  86. 8.15.1 CiplaVet Company Information
  87. 8.15.2 CiplaVet Business Overview
  88. 8.15.3 CiplaVet Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CiplaVet Praziquantel Product Portfolio
  90. 8.15.5 CiplaVet Recent Developments
  91. 8.16 Chanelle Pharma
  92. 8.16.1 Chanelle Pharma Company Information
  93. 8.16.2 Chanelle Pharma Business Overview
  94. 8.16.3 Chanelle Pharma Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Chanelle Pharma Praziquantel Product Portfolio
  96. 8.16.5 Chanelle Pharma Recent Developments
  97. 8.17 Ceva Santé Animale
  98. 8.17.1 Ceva Santé Animale Company Information
  99. 8.17.2 Ceva Santé Animale Business Overview
  100. 8.17.3 Ceva Santé Animale Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ceva Santé Animale Praziquantel Product Portfolio
  102. 8.17.5 Ceva Santé Animale Recent Developments
  103. 8.18 C and H Generics
  104. 8.18.1 C and H Generics Company Information
  105. 8.18.2 C and H Generics Business Overview
  106. 8.18.3 C and H Generics Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 C and H Generics Praziquantel Product Portfolio
  108. 8.18.5 C and H Generics Recent Developments
  109. 8.19 Auvex
  110. 8.19.1 Auvex Company Information
  111. 8.19.2 Auvex Business Overview
  112. 8.19.3 Auvex Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Auvex Praziquantel Product Portfolio
  114. 8.19.5 Auvex Recent Developments
  115. 8.20 AniMedica
  116. 8.20.1 AniMedica Company Information
  117. 8.20.2 AniMedica Business Overview
  118. 8.20.3 AniMedica Praziquantel Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 AniMedica Praziquantel Product Portfolio
  120. 8.20.5 AniMedica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Praziquantel Value Chain Analysis
  2. 9.1.1 Praziquantel Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Praziquantel Production Mode & Process
  6. 9.2 Praziquantel Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Praziquantel Distributors
  9. 9.2.3 Praziquantel Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst